Abbott India Limited

NSEI:ABBOTINDIA Stock Report

Market Cap: ₹575.4b

Abbott India Past Earnings Performance

Past criteria checks 5/6

Abbott India has been growing earnings at an average annual rate of 17.4%, while the Pharmaceuticals industry saw earnings growing at 14.9% annually. Revenues have been growing at an average rate of 9.4% per year. Abbott India's return on equity is 36.8%, and it has net margins of 19.9%.

Key information

17.4%

Earnings growth rate

17.4%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate9.4%
Return on equity36.8%
Net Margin19.9%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?

Feb 23
Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?

Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price

Jan 07
Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price

Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's

Jul 15
Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's

Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00

Jul 01
Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00

Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00

May 22
Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00

With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case

Apr 14
With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case

Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?

Mar 06
Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?

Is Now The Time To Put Abbott India (NSE:ABBOTINDIA) On Your Watchlist?

Dec 31
Is Now The Time To Put Abbott India (NSE:ABBOTINDIA) On Your Watchlist?

We Think Abbott India (NSE:ABBOTINDIA) Can Manage Its Debt With Ease

Mar 16
We Think Abbott India (NSE:ABBOTINDIA) Can Manage Its Debt With Ease

Here's Why We Think Abbott India (NSE:ABBOTINDIA) Is Well Worth Watching

Jan 28
Here's Why We Think Abbott India (NSE:ABBOTINDIA) Is Well Worth Watching

A Look At The Intrinsic Value Of Abbott India Limited (NSE:ABBOTINDIA)

Dec 05
A Look At The Intrinsic Value Of Abbott India Limited (NSE:ABBOTINDIA)

Do Abbott India's (NSE:ABBOTINDIA) Earnings Warrant Your Attention?

Oct 30
Do Abbott India's (NSE:ABBOTINDIA) Earnings Warrant Your Attention?

Abbott India (NSE:ABBOTINDIA) Has A Rock Solid Balance Sheet

Sep 18
Abbott India (NSE:ABBOTINDIA) Has A Rock Solid Balance Sheet

Should You Be Adding Abbott India (NSE:ABBOTINDIA) To Your Watchlist Today?

Jul 16
Should You Be Adding Abbott India (NSE:ABBOTINDIA) To Your Watchlist Today?

How Does Abbott India Limited (NSE:ABBOTINDIA) Stand Up To These Simple Dividend Safety Checks?

Mar 24
How Does Abbott India Limited (NSE:ABBOTINDIA) Stand Up To These Simple Dividend Safety Checks?

The Abbott India (NSE:ABBOTINDIA) Share Price Is Up 197% And Shareholders Are Boasting About It

Mar 03
The Abbott India (NSE:ABBOTINDIA) Share Price Is Up 197% And Shareholders Are Boasting About It

Is Weakness In Abbott India Limited (NSE:ABBOTINDIA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Feb 04
Is Weakness In Abbott India Limited (NSE:ABBOTINDIA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

How Much Of Abbott India Limited (NSE:ABBOTINDIA) Do Institutions Own?

Jan 14
How Much Of Abbott India Limited (NSE:ABBOTINDIA) Do Institutions Own?

Abbott India Limited (NSE:ABBOTINDIA) Is An Attractive Dividend Stock - Here's Why

Dec 24
Abbott India Limited (NSE:ABBOTINDIA) Is An Attractive Dividend Stock - Here's Why

Announcing: Abbott India (NSE:ABBOTINDIA) Stock Increased An Energizing 185% In The Last Five Years

Dec 03
Announcing: Abbott India (NSE:ABBOTINDIA) Stock Increased An Energizing 185% In The Last Five Years

Is There More To The Story Than Abbott India's (NSE:ABBOTINDIA) Earnings Growth?

Nov 12
Is There More To The Story Than Abbott India's (NSE:ABBOTINDIA) Earnings Growth?

Is Abbott India Limited's (NSE:ABBOTINDIA) Recent Performance Tethered To Its Attractive Financial Prospects?

Oct 25
Is Abbott India Limited's (NSE:ABBOTINDIA) Recent Performance Tethered To Its Attractive Financial Prospects?

Do Institutions Own Abbott India Limited (NSE:ABBOTINDIA) Shares?

Oct 04
Do Institutions Own Abbott India Limited (NSE:ABBOTINDIA) Shares?

Why Abbott India Limited (NSE:ABBOTINDIA) Should Be In Your Dividend Portfolio

Sep 13
Why Abbott India Limited (NSE:ABBOTINDIA) Should Be In Your Dividend Portfolio

Abbott India Limited (NSE:ABBOTINDIA) Looks Interesting, And It's About To Pay A Dividend

Aug 23
Abbott India Limited (NSE:ABBOTINDIA) Looks Interesting, And It's About To Pay A Dividend

Is Abbott India's (NSE:ABBOTINDIA) 295% Share Price Increase Well Justified?

Aug 17
Is Abbott India's (NSE:ABBOTINDIA) 295% Share Price Increase Well Justified?

Earnings Tell The Story For Abbott India Limited (NSE:ABBOTINDIA)

Jul 27
Earnings Tell The Story For Abbott India Limited (NSE:ABBOTINDIA)

What You Need To Know About Abbott India Limited's (NSE:ABBOTINDIA) Investor Composition

Jul 06
What You Need To Know About Abbott India Limited's (NSE:ABBOTINDIA) Investor Composition

Revenue & Expenses Breakdown
Beta

How Abbott India makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:ABBOTINDIA Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2357,53411,4566,7990
30 Sep 2356,38410,8146,7600
30 Jun 2355,23610,3406,8280
31 Mar 2353,4879,4946,8550
31 Dec 2252,6549,2947,2850
30 Sep 2251,6328,8187,3480
30 Jun 2250,0588,0867,4220
31 Mar 2249,1337,9877,3560
31 Dec 2147,5987,3986,8520
30 Sep 2146,3087,1776,6320
30 Jun 2144,6367,0616,2960
31 Mar 2143,1006,9076,1260
31 Dec 2041,7576,4926,3450
30 Sep 2041,5866,5876,3390
30 Jun 2041,5856,5634,8440
31 Mar 2040,9315,9296,2270
31 Dec 1940,3835,9526,3570
30 Sep 1939,0775,2556,2310
30 Jun 1938,3264,8496,0760
31 Mar 1936,7864,5036,0220
31 Dec 1835,6064,3725,7270
30 Sep 1834,9414,3555,5750
30 Jun 1834,4604,3545,5060
31 Mar 1832,9854,0125,3250
31 Dec 1732,2423,4324,7600
30 Sep 1730,8933,1344,7270
30 Jun 1728,7942,5094,6130
31 Mar 1729,0262,7664,5170
31 Dec 1628,9592,9804,4020
30 Sep 1628,0972,8024,4030
30 Jun 1627,2932,6634,4030
31 Mar 1626,1452,5534,4440
31 Dec 1525,3802,5046,1940
30 Sep 1524,5042,4456,1090
30 Jun 1523,9502,4666,0160
31 Mar 1522,8932,2904,0020
31 Dec 1422,0082,1765,9430
30 Sep 1421,1032,0655,7060
30 Jun 1419,7761,8805,5580
31 Mar 1418,6941,6685,5410
31 Dec 1317,5271,6012,3130
30 Sep 1317,5801,2734,2970
30 Jun 1317,1961,4954,2490
31 Mar 1316,9281,2024,1990

Quality Earnings: ABBOTINDIA has high quality earnings.

Growing Profit Margin: ABBOTINDIA's current net profit margins (19.9%) are higher than last year (17.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ABBOTINDIA's earnings have grown by 17.4% per year over the past 5 years.

Accelerating Growth: ABBOTINDIA's earnings growth over the past year (23.3%) exceeds its 5-year average (17.4% per year).

Earnings vs Industry: ABBOTINDIA earnings growth over the past year (23.3%) did not outperform the Pharmaceuticals industry 23.8%.


Return on Equity

High ROE: ABBOTINDIA's Return on Equity (36.8%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.